<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00956462</url>
  </required_header>
  <id_info>
    <org_study_id>Trope2009</org_study_id>
    <nct_id>NCT00956462</nct_id>
  </id_info>
  <brief_title>Steroids Versus Non-steroidal Anti-inflammatory Drugs Following Glaucoma Surgery</brief_title>
  <official_title>Topical Steroids Versus Topical Non-steroidal Anti-inflammatory Drugs Following Ahmed Valve Glaucoma Drainage Device Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the eye pressure response to non-steroidal anti-inflammatory eye
      drops as compared to steroid eye drops following glaucoma surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glaucoma is a chronic disease of the eye which results in gradual loss of nerve fibres,
      resulting in visual loss. The mainstay of treatment is reduction of intraocular pressure
      (IOP), which has been shown to preserve vision, and glaucoma surgery aims to achieve this.
      One type of surgery involves insertion of a glaucoma drainage device (GDD). Following surgery
      steroid eye drops are commonly used in order to reduce the inflammation that occurs as a
      result of the surgery. However, a common side effect of steroid eye drops is a rise in eye
      pressure. Non-steroidal anti-inflammatory drugs (NSAID) eye drops do not have this side
      effect and are used as an alternative to steroids following other types of eye surgery. Use
      of NSAID drops following GDD surgery may result in improved eye pressure. This study aims to
      evaluate the eye pressure response to NSAID eye drops following GDD surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>Six weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>NSAID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Steroids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac (NSAID) versus Dexamethasone (steroid)</intervention_name>
    <description>Topical NSAID versus topical steroid after implantation of glaucoma drainage device</description>
    <arm_group_label>NSAID</arm_group_label>
    <arm_group_label>Steroids</arm_group_label>
    <other_name>Acular (NSAID)</other_name>
    <other_name>Maxidex (steroid)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 - 85 years of age

          2. Undergoing glaucoma drainage device surgery

        Exclusion criteria

          1. Unable to consent

          2. Undergoing combined GDD and cataract surgery

          3. Patients with conditions requiring additional anti-inflammatory medications e.g.,
             uveitic glaucoma, previous corneal transplant

          4. Patients with prior history of corneal ulceration

          5. Breast-feeding (nursing) mothers

          6. Pregnant or planning to become pregnant during the trial period

          7. Allergic to Ketorolac Tromethamine, or had an allergic-type reaction to
             acetylsalicylic acid or other non-steroidal anti-inflammatory drugs used for pain
             relief or arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graham Trope, MD FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Graham E Trope, Professor</last_name>
    <phone>416-603-5317</phone>
    <email>Graham.Trope@uhn.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Graham Trope</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Graham Trope</last_name>
      <phone>416.603.5317</phone>
      <email>Graham.Trope@uhn.on.ca</email>
    </contact>
    <investigator>
      <last_name>Tariq A Alasbali</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Darana Yuen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Smith</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yvonne Buys</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2009</study_first_submitted>
  <study_first_submitted_qc>August 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2009</study_first_posted>
  <last_update_submitted>August 7, 2009</last_update_submitted>
  <last_update_submitted_qc>August 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>University Health Network, Toronto</name_title>
    <organization>University Health Network, toronto</organization>
  </responsible_party>
  <keyword>intraocular pressure</keyword>
  <keyword>Ahmed valve</keyword>
  <keyword>NSAIDS</keyword>
  <keyword>steroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>January 10, 2015</submitted>
    <returned>January 20, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

